(PARIS, FRANCE) February 4, 2021 – Therapixel Inc. and Emory University Department of Radiology & Imaging Sciences Breast Imaging Division announced today the start of a research project under the supervision of Rebecca Seidel, MD (Principal Investigator) and Elizabeth Krupinski, PhD. Under the terms of this collaboration, Emory will utilize Therapixel’s mammogram reading software as an aid in the education process by assessing the ability of this AI-powered technology to improve radiology trainees’ screening mammography interpretation skills.

Having received the FDA 510(k) clearance K192854 in March 2020, MammoScreen has been successfully used by US radiologists as decision-making support for breast cancer screening and received numerous positive reviews due to its user-friendly interface. Exploring the potential of this powerful tool in medical education is an additional step toward evaluating its overall function and value in the future of radiology.

Ensuring the highest quality of radiology residency training is critically important. About 60% of radiologists interpret screening mammograms in their daily practice. However, less than 3% undergo an additional year of breast-specific fellowship training, making the training received during residency crucial for future success. Traditionally, radiology trainees learn to interpret screening mammograms by reviewing cases under the guidance of experienced radiologists. The purpose of this study is to determine if review of a teaching file with Mammoscreen’s AI is an effective tool to enhance traditional instruction at the viewbox. The teaching file is enriched with malignancies and can be reviewed independently, at the trainee’s own pace. This may prove especially useful in this period of social distancing.

“The use of AI to improve clinical performance and workflow in the interpretation of screening mammography is an area of active research. However, little has been done to evaluate the potential of AI as a teaching aid for trainees” points out Rebecca Seidel, Associate Professor at Emory University School of Medicine. “Therefore, we feel enthusiastic about studying MammoScreen as a tool to enhance training in screening mammography ”, she added.

“AI is increasingly supporting radiologists in their day-to-day clinical practice, therefore integrating AI into conventional radiology training is an important element for future radiologists’ education. We are glad to have the opportunity to develop these educational capabilities in a collaboration with a renowned medical school.” says Matthieu Leclerc-Chalvet, CEO of Therapixel.

MammoScreen™ is an artificial intelligence-based software that identifies regions suspicious for cancer on screening mammograms and assesses their likelihood of malignancy. The system detects and characterizes abnormal findings on a scale from one to ten called the MammoScreen™ score. The probability of malignancy increases with the score to reaching a very high likelihood of malignancy for the highest scores, while the findings with a low score are highly unlikely to be malignant.

About Therapixel

Therapixel specializes in the design and commercialization of AI-powered medical imaging software, with the goal of delivering pertinent information at the right time to healthcare professionals. Winner of the Digital Mammography DREAM Challenge in 2017, the global competition on breast cancer detection with AI, Therapixel has developed MammoScreen™, a software that helps with the interpretation of screening mammograms. With MammoScreen™, even experienced radiologists can improve their performance, feel more confident in their judgment and reassure women quicker. Find more at www.mammoscreen.com

About Emory University Department of Radiology & Imaging Sciences Breast Imaging Division

Emory University Department of Radiology & Imaging Sciences Breast Imaging Division is composed of dedicated breast imaging faculty and fellows who work together to accomplish the academic tripartite mission of research, education, and clinical excellence. Clinical education is centered on the daily care of patients delivered at the Winship Glenn Family Breast Imaging Center at Emory University Hospital, Center for Breast Care at Emory Johns Creek Hospital, Ed and Dora Voyles Breast Health Center at Emory Saint Joseph’s Hospital, Emory University Hospital Midtown, and Georgia Cancer Center for Excellence at Grady Memorial Hospital. Interaction with breast surgeons, breast pathologists, radiation oncologists, plastic surgeons, and medical oncologists occurs on a daily basis and further enhances the precepts of multidisciplinary patient management and team practice. All breast imaging faculty members are engaged in clinical research and welcome the opportunity to share their projects and experience with medical students, residents, and fellows. This division also is active within the community, presenting information at various locations to facilitate education and awareness.

Media Contacts
Neliya Tumbeva
media @ therapixel.com
www.therapixel.com